HRTX
Heron Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.88
-0.05 ▼ -4.98%
🌙 3월 13일 7:30 PM ET (한국 3/14 08:30)
$0.90
+0.02 ▲ +2.08%
| Index | RUT | P/E | - | EPS (ttm) | -0.12 | Insider Own | 1.57% | Shs Outstand | 0.19B | Perf Week | -8.78% |
| Market Cap | 0.17B | Forward P/E | 6.78 | EPS next Y | 750% | Insider Trans | - | Shs Float | 0.19B | Perf Month | -24.64% |
| Enterprise Value | 0.26B | PEG | - | EPS next Q | -0.01 | Inst Own | 82.49% | Short Float | 20.01% | Perf Quarter | -35.64% |
| Income | -0.02B | P/S | 1.07 | EPS this Y | 83.33% | Inst Trans | -0.64% | Short Ratio | 21.34 | Perf Half Y | -31.12% |
| Sales | 0.15B | P/B | 12.5 | EPS next 5Y | - | ROA | -4.47% | Short Interest | 37.13M | Perf YTD | -32.18% |
| Book/sh | 0.07 | P/C | 3.56 | EPS past 3/5Y | 58.31% 45.44% | ROE | - | 52W High | -66.22% ($2.61) | Perf Year | -62% |
| Cash/sh | 0.25 | P/FCF | - | Sales past 3/5Y | 12.89% 11.81% | ROIC | -13.03% | 52W Low | -3.02% ($0.91) | Perf 3Y | -63.26% |
| Dividend Est. | - | EV/EBITDA | 933.18 | EPS Y/Y TTM | -30.68% | Gross Margin | 73.31% | Volatility(W/M) | 7.62% 8.24% | Perf 5Y | -94.8% |
| Dividend TTM | - | EV/Sales | 1.69 | Sales Y/Y TTM | 7.36% | Oper. Margin | -1.32% | ATR (14) | 0.08 | Perf 10Y | -95.31% |
| Dividend Ex-Date | - | Quick Ratio | 1.51 | EPS Q/Q | -165.69% | Profit Margin | -13.04% | RSI (14) | 26.67 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.48 | Sales Q/Q | -0.47% | SMA20 | -19.48% ($1.09) | Beta | 1.35 | Target Price | $4.33 |
| Payout | - | Debt/Eq | 9.81 | Earnings | 2000000 | SMA50 | -29.2% ($1.24) | Rel Volume | 1.22 | Prev Close | $0.93 |
| Employees | 128 | LT Debt/Eq | 9.81 | EPS/Sales Surpr. | - 1.81% | SMA200 | -38.8% ($1.44) | Avg Volume(3M) | 1.74M | Price | $0.88 |
| IPO | 1987/8/26 | Option/Short | Yes/Yes | Trades | 3394 | Volume | 2,114,971 | Change | -4.98% |
뉴스 로딩 중...